Clinical trial
Comparison of Combination Chemotherapy Regimens in Treating Patients With…
NCT00003172 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003172 |
|---|---|
| Title | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer |
| Official title | Randomized Phase II Trial of Either 5-Fluorouracil, Recombinant Alfa-2a-Interferon and Intravenous Hydroxyurea With Filgrastim Support (FHIG) or Doxorubicin/Docetaxel (Dd) in Patients With Advanced Gastric Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, recombinant interferon alfa, docetaxel, doxorubicin hydrochloride, fluorouracil, hydroxyurea |
| Start date | Dec 1, 1997 |
| Completion | Sep 1, 2004 |
| First posted | Sep 6, 2004 |
| Last update posted | Jun 21, 2013 |
| Countries | South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: